We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
-13%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$46B
AUM Growth
-$5.82B
Cap. Flow
+$1.91B
Cap. Flow %
4.16%
Top 10 Hldgs %
16.37%
Holding
3,033
New
111
Increased
2,420
Reduced
427
Closed
53

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$127M
2
CI icon
Cigna
CI
+$54M
3
CVS icon
CVS Health
CVS
+$38.8M
4
MPC icon
Marathon Petroleum
MPC
+$28.9M
5
FANG icon
Diamondback Energy
FANG
+$19M

Sector Composition

Rank Sector Weight
1 Technology 16.95%
2 Financials 15.85%
3 Healthcare 14.41%
4 Consumer Discretionary 10.13%
5 Industrials 10.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STBZ
1926
DELISTED
State Bank Financial Corporation. Common Stock
STBZ
$1.18M ﹤0.01%
54,745
+18,363
+50% +$458K
TTEC icon
1927
TTEC Holdings
TTEC
$127M
$1.18M ﹤0.01%
41,218
+6,662
+19% +$177K
REX icon
1928
REX American Resources
REX
$1.43B
$1.18M ﹤0.01%
103,626
+17,172
+20% +$201K
ALX
1929
Alexander's
ALX
$1.39B
$1.17M ﹤0.01%
3,853
+882
+30% +$281K
MBI icon
1930
MBIA
MBI
$269M
$1.17M ﹤0.01%
131,055
+38,254
+41% +$364K
OPB
1931
DELISTED
Opus Bank Common Stock
OPB
$1.16M ﹤0.01%
59,430
+9,743
+20% +$208K
HWKN icon
1932
Hawkins
HWKN
$2.71B
$1.16M ﹤0.01%
56,790
+9,402
+20% +$183K
OSPN icon
1933
OneSpan
OSPN
$598M
$1.16M ﹤0.01%
89,749
+15,691
+21% +$255K
CIR
1934
DELISTED
CIRCOR International, Inc
CIR
$1.16M ﹤0.01%
54,522
+8,495
+18% +$282K
EZPW icon
1935
Ezcorp Inc
EZPW
$1.8B
$1.16M ﹤0.01%
149,453
+24,254
+19% +$230K
CLVS
1936
DELISTED
Clovis Oncology, Inc.
CLVS
$1.15M ﹤0.01%
63,962
+19,840
+45% +$405K
MSEX icon
1937
Middlesex Water
MSEX
$1.08B
$1.15M ﹤0.01%
21,524
+7,370
+52% +$363K
CDNA icon
1938
CareDx
CDNA
$2.32B
$1.14M ﹤0.01%
45,357
+15,752
+53% +$405K
CIVI
1939
DELISTED
Civitas Resources
CIVI
$1.13M ﹤0.01%
54,671
+9,758
+22% +$257K
DAY
1940
DELISTED
Dayforce
DAY
$1.13M ﹤0.01%
32,722
+9,187
+39% +$343K
VRS
1941
DELISTED
Verso Corporation
VRS
$1.13M ﹤0.01%
50,279
+15,075
+43% +$407K
CDXS icon
1942
Codexis
CDXS
$159M
$1.12M ﹤0.01%
67,303
+22,383
+50% +$386K
HTZ
1943
DELISTED
Hertz Global Holdings, Inc.
HTZ
$1.12M ﹤0.01%
94,696
+27,466
+41% +$386K
FFIC
1944
DELISTED
Flushing Financial
FFIC
$1.12M ﹤0.01%
52,131
+12,525
+32% +$280K
QUOT
1945
DELISTED
Quotient Technology Inc
QUOT
$1.12M ﹤0.01%
104,916
+34,070
+48% +$427K
FRPT icon
1946
Freshpet
FRPT
$3.28B
$1.12M ﹤0.01%
34,841
+11,176
+47% +$389K
GFF icon
1947
Griffon
GFF
$4.88B
$1.12M ﹤0.01%
106,954
+17,640
+20% +$224K
AAMI
1948
Acadian Asset Management
AAMI
$3.26B
$1.12M ﹤0.01%
104,640
+33,986
+48% +$409K
PRIM icon
1949
Primoris Services
PRIM
$4.35B
$1.12M ﹤0.01%
58,365
+18,734
+47% +$420K
WIFI
1950
DELISTED
Boingo Wireless, Inc.
WIFI
$1.11M ﹤0.01%
54,225
+17,587
+48% +$468K

Similar funds

RhumbLine Advisers's Q4 2018 Portfolio in Review

As of Q4 2018, RhumbLine Advisers held 3,033 positions worth $46B, down 11% from $51.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

RhumbLine Advisers deployed $1.91B of net new capital in Q4 2018, opening 111 new positions and adding to 2,420 existing holdings. Its largest new stake was Linde: 805,738 shares worth $126M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Apple, an estimated $30.2M trimmed.

  • RhumbLine Advisers's largest Q4 2018 buy was Linde: 805,738 shares worth $126M.
  • RhumbLine Advisers added most to Cigna in Q4 2018, an estimated $54M increase.
  • RhumbLine Advisers's biggest Q4 2018 reduction was Apple, cutting an estimated $30.2M.
  • RhumbLine Advisers fully exited Aetna Inc in Q4 2018, selling an estimated $124M.
  • RhumbLine Advisers's ten largest holdings make up 16% of its $46B portfolio in Q4 2018.
  • RhumbLine Advisers opened 111 new positions and closed 53 in Q4 2018.
  • RhumbLine Advisers's portfolio value fell 11% quarter-over-quarter to $46B.

Based on RhumbLine Advisers's 13F filing for Q4 2018, filed 31 Jan 2019.